share_log

Jefferies Downgrades Rallybio to Hold, Lowers Price Target to $1.5

Benzinga ·  Feb 7 20:02

Jefferies analyst Eun Yang downgrades Rallybio (NASDAQ:RLYB) from Buy to Hold and lowers the price target from $7 to $1.5.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment